MedPath

Comparison of ketamine and midazolam in management of refractory status epilepticus in children.

Not Applicable
Conditions
Health Condition 1: G408- Other epilepsy and recurrent seizures
Registration Number
CTRI/2024/07/069791
Lead Sponsor
Maulana Azad Medical College
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Children presenting in the Department of Paediatrics fulfilling the criteria for refractory status epilepticus in the age group of 1 month to 12 years.

Exclusion Criteria

Patients presenting with Traumatic Brain Injury.

Known allergy or anaphylaxis due to Ketamine or Midazolam.

Children presenting with stage 2 hypertension i.e., more than 95th centile plus 12mmHg.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath